Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q3 EPS of ($0.25), $0.22 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.